Growth Metrics

Inogen (INGN) Debt Ratio (2013 - 2016)

Inogen (INGN) reported Debt Ratio of 0.0 for Q3 2016, down 84.75% year-over-year from 0.0 in Q4 2015, and down 52.97% on a QoQ basis from 0.0 in Q2 2016.

Inogen (INGN) has 4 years of Debt Ratio data on file, last reported at 0.0 in Q3 2016.

  • Quarterly Debt Ratio fell 84.75% year-over-year to 0.0 in Q3 2016, while the trailing twelve-month figure through Sep 2016 was 0.0 (down 84.75% YoY) and the FY2015 annual result came in at 0.0, down 55.45% from the prior year.
  • Debt Ratio fell to 0.0 in Q3 2016 per INGN's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.13 in Q4 2013 and bottomed at 0.0 in Q3 2016.
  • The 4-year median for Debt Ratio is 0.0 (2015), against an average of 0.03.
  • Peak annual rise in Debt Ratio reached 48.24% in 2015, while the deepest fall reached 96.79% in 2015.
  • Tracing INGN's Debt Ratio over 4 years: stood at 0.13 in 2013, then tumbled by 96.61% to 0.0 in 2014, then slumped by 55.45% to 0.0 in 2015, then tumbled by 80.61% to 0.0 in 2016.
  • Per Business Quant, the three latest INGN Debt Ratio figures stand at 0.0 (Q3 2016), 0.0 (Q2 2016), and 0.0 (Q1 2016).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.31
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.31
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.25
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.27
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.18
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 0.00
Jun 30, 2016 0.00
Mar 31, 2016 0.00
Dec 31, 2015 0.00
Sep 30, 2015 0.00
Jun 30, 2015 0.00
Mar 31, 2015 0.00
Dec 31, 2014 0.00
Sep 30, 2014 0.00
Jun 30, 2014 0.09
Mar 31, 2014 0.07
Dec 31, 2013 0.13